FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1702502468> ?p ?o ?g. }

• W1702502468 endingPage "2329" @default.
• W1702502468 startingPage "2321" @default.
• W1702502468 abstract "Treatment options after first-line chemotherapy are limited in non-small cell lung cancer (NSCLC). Belagenpumatucel-L is a therapeutic vaccine comprised of 4 transforming growth factor (TGF)-β2-antisense gene-modified, irradiated, allogeneic NSCLC cell lines that may be useful for maintenance after initial treatment.Stage III/IV NSCLC patients who did not progress after platinum-based chemotherapy were randomised 1:1 to receive maintenance belagenpumatucel-L or placebo. Patients were eligible for randomisation between one and four months from the end of induction chemotherapy. The primary endpoint was overall survival.This phase III trial enrolled 270 patients in the belagenpumatucel-L arm and 262 in the control arm. Belagenpumatucel-L was well tolerated with no serious safety concerns. There was no difference in survival between the arms (median survival 20.3 versus 17.8months with belagenpumatucel-L versus placebo, respectively; hazard ratio (HR) 0.94, p=0.594). There were also no differences in progression-free survival (4.3months versus 4.0 for belagenpumatucel-L vs placebo, respectively; HR 0.99, p=0.947). A prespecified Cox regression analysis demonstrated that the time elapsed between randomisation and the end of induction chemotherapy had a significant impact on survival (p=0.002) and that prior radiation was a positive prognostic factor (median survival 28.4months with belagenpumatucel-L versus 16.0months with placebo; HR 0.61, p=0.032).Although the overall trial did not meet its survival endpoint, improved survival for belagenpumatucel-L is suggested in patients who were randomised within 12weeks of completion of chemotherapy and in those who had received prior radiation. Further studies of belagenpumatucel-L in NSCLC are warranted." @default.
• W1702502468 created "2016-06-24" @default.
• W1702502468 creator A5013730320 @default.
• W1702502468 creator A5017657024 @default.
• W1702502468 creator A5020824873 @default.
• W1702502468 creator A5022063365 @default.
• W1702502468 creator A5028453258 @default.
• W1702502468 creator A5029924041 @default.
• W1702502468 creator A5032189899 @default.
• W1702502468 creator A5036466135 @default.
• W1702502468 creator A5042013205 @default.
• W1702502468 creator A5055054082 @default.
• W1702502468 creator A5059214557 @default.
• W1702502468 creator A5060287300 @default.
• W1702502468 creator A5063427877 @default.
• W1702502468 creator A5066661309 @default.
• W1702502468 creator A5073746419 @default.
• W1702502468 creator A5080900088 @default.
• W1702502468 creator A5082061757 @default.
• W1702502468 creator A5085257858 @default.
• W1702502468 date "2015-11-01" @default.
• W1702502468 modified "2023-10-05" @default.
• W1702502468 title "A phase III study of belagenpumatucel-L, an allogeneic tumour cell vaccine, as maintenance therapy for non-small cell lung cancer" @default.
• W1702502468 cites W1965067028 @default.
• W1702502468 cites W1965710621 @default.
• W1702502468 cites W1978845670 @default.
• W1702502468 cites W1978976304 @default.
• W1702502468 cites W1993615391 @default.
• W1702502468 cites W2000366267 @default.
• W1702502468 cites W2002419738 @default.
• W1702502468 cites W2006846913 @default.
• W1702502468 cites W2023479489 @default.
• W1702502468 cites W2036159305 @default.
• W1702502468 cites W2038441545 @default.
• W1702502468 cites W2054961201 @default.
• W1702502468 cites W2062364134 @default.
• W1702502468 cites W2082623135 @default.
• W1702502468 cites W2088720324 @default.
• W1702502468 cites W2100912832 @default.
• W1702502468 cites W2103496546 @default.
• W1702502468 cites W2112621029 @default.
• W1702502468 cites W2114300639 @default.
• W1702502468 cites W2117333200 @default.
• W1702502468 cites W2122476064 @default.
• W1702502468 cites W2124430059 @default.
• W1702502468 cites W2127733313 @default.
• W1702502468 cites W2128083415 @default.
• W1702502468 cites W2130593623 @default.
• W1702502468 cites W2138065068 @default.
• W1702502468 cites W2141285069 @default.
• W1702502468 cites W2146571367 @default.
• W1702502468 cites W2147996829 @default.
• W1702502468 cites W2156763707 @default.
• W1702502468 cites W2161872048 @default.
• W1702502468 cites W2169961966 @default.
• W1702502468 cites W2172273197 @default.
• W1702502468 cites W2916080668 @default.
• W1702502468 cites W4211221095 @default.
• W1702502468 doi "https://doi.org/10.1016/j.ejca.2015.07.035" @default.
• W1702502468 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26283035" @default.
• W1702502468 hasPublicationYear "2015" @default.
• W1702502468 type Work @default.
• W1702502468 sameAs 1702502468 @default.
• W1702502468 citedByCount "183" @default.
• W1702502468 countsByYear W17025024682015 @default.
• W1702502468 countsByYear W17025024682016 @default.
• W1702502468 countsByYear W17025024682017 @default.
• W1702502468 countsByYear W17025024682018 @default.
• W1702502468 countsByYear W17025024682019 @default.
• W1702502468 countsByYear W17025024682020 @default.
• W1702502468 countsByYear W17025024682021 @default.
• W1702502468 countsByYear W17025024682022 @default.
• W1702502468 countsByYear W17025024682023 @default.
• W1702502468 crossrefType "journal-article" @default.
• W1702502468 hasAuthorship W1702502468A5013730320 @default.
• W1702502468 hasAuthorship W1702502468A5017657024 @default.
• W1702502468 hasAuthorship W1702502468A5020824873 @default.
• W1702502468 hasAuthorship W1702502468A5022063365 @default.
• W1702502468 hasAuthorship W1702502468A5028453258 @default.
• W1702502468 hasAuthorship W1702502468A5029924041 @default.
• W1702502468 hasAuthorship W1702502468A5032189899 @default.
• W1702502468 hasAuthorship W1702502468A5036466135 @default.
• W1702502468 hasAuthorship W1702502468A5042013205 @default.
• W1702502468 hasAuthorship W1702502468A5055054082 @default.
• W1702502468 hasAuthorship W1702502468A5059214557 @default.
• W1702502468 hasAuthorship W1702502468A5060287300 @default.
• W1702502468 hasAuthorship W1702502468A5063427877 @default.
• W1702502468 hasAuthorship W1702502468A5066661309 @default.
• W1702502468 hasAuthorship W1702502468A5073746419 @default.
• W1702502468 hasAuthorship W1702502468A5080900088 @default.
• W1702502468 hasAuthorship W1702502468A5082061757 @default.
• W1702502468 hasAuthorship W1702502468A5085257858 @default.
• W1702502468 hasConcept C10515644 @default.
• W1702502468 hasConcept C121608353 @default.
• W1702502468 hasConcept C126322002 @default.
• W1702502468 hasConcept C141071460 @default.
• W1702502468 hasConcept C142724271 @default.
• W1702502468 hasConcept C143998085 @default.

• next